P3-225: Intraoperative lavage cytology of surgical margins in patients undergoing limited surgery for small lung cancer: Control of postoperative local failure at surgical margins in the pulmonary parenchyma  by Higashiyama, Masahiko et al.
Copyright © 2007 by the International Association for the Study of Lung Cancer S775
Journal of Thoracic Oncology • Volume 2, Number 8, Supplement 4, August 2007  12th World Conference on Lung Cancer
atrium, and aorta each in 2, and diaphragm and innominate vein each 
in 1. Nineteen patients (50%) had stage III disease, 12 (32%) had stage 
I disease, 6 (16%) had stage II disease, and 1 (2%) had IV disease. 
Twenty-seven patients (71%) had squamous cell carcinoma, 8 (20%) 
had adenocarcinoma, 1 (3%) had large cell carcinoma, 1 (3%) had 
carcinoid, and 1 (3%) had mucoepidermoid carcinoma.
Twenty-ﬁve patients (66%) had anemia before surgery, and the mean 
serum hemoglobin concentration of all patients with postobstructive 
pneumonia was 12.4 g/dl (range, 7.9-17.3 g/dl). No patients were trans-
fused before surgery.
Univariate and multivariate analyses of the development of PRCs were 
performed in 13 PRC and 25 non-PRC patients who underwent lung 
resection from January 1983 to December 2005. 
Results: PRCs developed in 13 of the 38 patients (34.2%) with lung 
cancer associated with postobstructive pneumonia. PRCs developed in 
13 of the 38 patients (34.2%); pneumonia in 7, BPF in 3, and pyotho-
rax, broncho-pulmonary artery ﬁstula, and a prolonged air leakage each 
in 1. Four patients (10.5%) died during hospitalization caused by mas-
sive hemoptysis due to broncho-pulmonary artery ﬁstula 31 days after 
surgery, acute myocardial infarction 16 days after surgery, bilateral 
pneumonia 56 days after surgery, and pneumonia and cerebral infarc-
tion 13 days after surgery, respectively. 
Serum hemoglobin concentration before surgery and predicted post-
operative FEV1.0 (ppoFEV1.0) were signiﬁcantly low in PRC group 
based on the univariate analyses (p=0.0049 and p=0.0084, respective-
ly). PpoFEV1.0 (odds ratio, 0.034; 95% conﬁdence intervals, 0.0001-
0.832; and p value, 0.0382) was the signiﬁcant risk factor based on a 
multivariate analysis. 
Conclusions: Mortality and morbidity is high in patients with lung 
cancer associated with postobstructive pneumonia. PRCs demonstrated 
signiﬁcant association with low ppoFEV1.0 and serum hemoglobin 
concentration, indicating the need for preoperative transfusion or bron-
choplasty if possible.
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It has been well-accepted that FDG-PET is useful for differential 
diagnosis of benign and malignant tumors, diagnosis of lymph node in-
volvement and distant metastasis, and evaluation of chemo- and radia-
tion therapy. We sought that FDG-PET may be useful for prediction of 
patients’ survival after surgical resection. In this study, we investigated 
a value of maximum standardized uptake value of FDG (maxSUV) as 
a predictor of lymph node involvement and survival in non-small cell 
lung cancers (NSCLC) undergoing surgical resection. 
Methods: One hundred and seventeen patients with primary lung can-
cer were studied. Sixty-eight of them are adenocarcinomas and 36 are 
squamous cell carcinoma. All patients underwent a complete resection 
within 6 wk of the 18F-FDG-PET study. maxSUV was used to interpret 
18F-FDG uptake within the primary lesions. Patients were divided into 
two groups according to maxSUV. maxSUV was correlated with clini-
copathological factors. The correlation between maxSUV and survival 
was analyzed using Cox regression tests. 
Results: High maxSUV (≥3) is signiﬁcantly correlated with male 
(p=0.001), higher T factor (≥2, p<0.001), larger size (≥20 mm, 
p<0.001), and lymph node involvement (p=0.002).
Survival of low maxSUV group was signiﬁcantly better(p=0.011).
Among 39 NSCLC with maxSUV < 2.0, lymph node involvement was 
positive in only one patient (2.5 %). Especially in small-sized tumor 
(≤20 mm), none of 24 patients had lymph node involvement. Multivari-
ate analysis showed that only maxSUV was an independent survival 
factor among maxSUV, T factor and lymph node involvement. 
Conclusion: Patients with a low maxSUV in the primary lesion had 
a signiﬁcantly lower risk of nodal involvement than did patients with 
a high maxSUV. Patients with a low maxSUV in NSCLC had a better 
prognosis than did patients with high maxSUV. maxSUV may be useful 
as a marker for limited resection.
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Background: Postoperative recurrence at the surgical margins in 
the pulmonary parenchyma is one of type of local failure in patients 
undergoing limited surgery for lung cancer. To prevent this type of 
recurrence, we have introduced a novel technique of intraoperative 
lavage cytology of the surgical margins during limited surgery (JTCVS 
125:101,2003). This study examined the usefulness of this technique 
in contributing to the control of local recurrence in patients with small 
lung cancer.
Patients: Between 1973 and July 2005, limited surgery including seg-
mentectomy and wide wedge resection were preoperatively scheduled 
for a total 280 consecutive peripheral lung cancer lesions (20mm or 
less) in our institute. Of these, 95 lesions underwent surgery before 
clinical application of this cytologic technique in October 1997, and 
185 lesions were treated after the initiation of this procedure.
Results: In the ﬁrst 89 lesions, limited surgery was performed except in 
6 cases that underwent intraoperative conversion to completion lobec-
tomy due to nodal involvement. In contrast, among the latter cases, this 
technique detected positive cytological ﬁndings at the surgical margin 
in 7 lesions (3.8%). The surgical mode was immediately converted 
for 3 lesions (completion lobectomy in 2, additional resection in one). 
Completion lobectomy was performed due to nodal involvement in 7 
lesions and due to technical disadvantage in one. Therefore, limited 
surgery was ﬁnally performed for 175 lesions in the latter group. Dur-
ing a median postoperative follow-up period of 47.7 months, ranging 
from 10.1 to 180.4 months, local recurrence in the surgical margin of 
the pulmonary parenchyma was observed in 5 patients (5.6%) in the 
former group, but in only one (0.6%) of the latter. Interestingly, among 
the patients in whom cytologically negative margin was conﬁrmed by 
this intraoperative checking system, there has not been any local failure 
at the surgical margin to date.
Conclusions: Although this study was based on historical analysis, this 
intraoperative lavage cytologic technique is a promising tool to control 
local recurrence at the surgical margin following limited surgery for 
small lung cancer. In promoting limited surgery for small lung cancer, 
it is necessary to determine the presence of residual tumor cells using 
this novel technique for checking the surgical margin status. Cytologi-
cally negative results may be a promising indicator to prevent postop-
erative local failure.
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Background: Thoracic effusion is common in patients with advanced 
lung cancer which means impossible for curative surgery. Palliative 
VATS surgery is used in this situation. 
Method: We performed VATS pleura biopsy and Pleurodesis in 34 lung 
cancer patients with malignant thoracic effusion from 2003 to 2006. 
Result: There were 23 male and 11 female, age ranged from 45-84, 
adenocarcinoma 20 and squame carcinoma 4. Before operation we got 
pathological diagnosis by thoracentesis. In operation we evacuated the 
thoracic cavity and sprinkled 5g talcum powder all over the pleura sur-
face, then we eject 40mg cisplatin in thoracic cavity. We placed water 
sealed drainage after surgery for 3 to 14 days depending on amount of 
discharges from the drainage tube. After surgery all patients received 
standard chemotherapy and radiothreapy. There was no death associ-
ated with operation and no recurrence of thoracic effusion after surgery. 
Conclusions: VATS pleura biopsy can get more tissue than thoracen-
tesis to do immunohistochemistry, for example EGFR, ERCC1 and so 
on, which may provide us signiﬁcant imformation for futher treatment. 
Pleurodesis have a good effect on controlling thoracic effusion which 
can improve life quality for patients.
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Background: Early stage non-small cell lung cancer(NSCLC) is 
potentially curable by surgery, but long-term outcome after surgical 
resection is limited by disease recurrence locally or at sites distant from 
the primary disease. We conducted a retrospective study of NSCLC pa-
tients who underwent curative-intent surgery with stage IB(T2N0M0) 
to evaluate outcome variables. 
Methods: Forty-seven consecutive patients(35 male, 12 female) 
received curative-intent resection for stage IB NSCLC from January 
1998 to December 2005. Outcome variables analyzed included sex, 
types of operative procedure, histologic type and grade, tumor size, 
visceral pleural involvement. 
Results: The median age was 64 years(range from 39 to 77) and 
median follow up duration was 36 months. The operative procedures 
used were lobectomy in 40 patients and pneumonectomy in 7 patients. 
Twenty-ﬁve patients had histology of squamous cell and 22 patients 
had nonsquamous cell(including 14 adenocarcinomas). The overall 
5-year survival rate was 65.9%. The disease free survival(DFS) and 
overall survival(OS) rate were signiﬁcantly poor in patients with larger 
tumor(diameter >= 4 cm) compared with smaller tumor(diameter < 4 
cm) (p=0.01 and p=0.009, respectively). Patients with visceral pleural 
involvement had poor DFS rate compared with patients without vis-
ceral pleural involvement (p=0.03).
Conclusions: Tumor size was related to poor DFS and OS, and visceral 
pleural involvement was related to poor DFS in patients with stage IB 
NSCLC. Those patients may need to have adjuvant systemic therapy 
for improvement of outcome.
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